Looking forward to seeing you at Medical Fair China 2019!
The only satellite exhibition of MEDICA in China, Medical Fair China 2019 is co-organized by Messe Dusseldorf (Shanghai) Co., Ltd. and China Service Alliance of Medical Devices Innovation, which will be held in Suzhou International Expo Centre from September 5 to 7, 2019. There will be over 300 domestic and international exhibitors displaying the world’s latest medical equipment and innovation technology in the 15,000-sqm exhibition hall, which are expected to attract over 15,000 medical top experts.
The exhibits focus on medical digital imaging products, optical and electronic products, in vitro diagnostic products, minimally invasive instruments, implantable and interventional medical devices, operating room equipment, laboratory equipment, new medical consumables, first aid and care products, rehabilitation devices and equipment, home medical equipment, smart medical products, medical equipment raw materials, components, accessories and software products and Innovation services. Medical Fair China 2019 is expected to attract over 15,000 professional visitors from hospitals and medical institutions, purchasers and suppliers of medical equipment raw materials, components, accessories and software products, medical device R&D institutions and manufacturers, medical device dealers, agents and retail traders, universities and research institutions, investment companies, government agencies and associations etc.
The brand of all concurrent events, Global Device Week 2019 which is mainly consisted of China Medical Devices Design & Startups Competition (CMDDSC2019), Devicechina 2019, China Medical Innovation Forum (CMIF2019), China Transformation Medicine & Innovation Service Forum (TMIS2019), FTR4H (Future for Health) Conference and other sub-forums, brings experts’ opinions to lead the medical innovation.
Medical Fair China 2019 is the perfect platform for exhibitors to display the latest medical equipment and innovation technology and communicate with professionals’ home and abroad. We cordially invite you to exhibit in Medical Fair China 2019 through which you will greatly expand the brand influence and generate new business.
Related news
-
The Chinese University of Hong Kong and Aurora Medical Technology Hong Kong to collaborate on breast cancer research program
Aurora Medical Technology Hong Kong (Aurora-HK) and The Chinese University of Hong Kong (CUHK) are pleased to announce the completion of a landmark collaboration agreement leveraging the shared interests and diverse expertise of the two entities.Led by Winnie chiu-wing Chu MD, Professor of radiology at CUHK and Abraham Morse MD, Medical Director of Aurora, the joint project will investigate the potential advantages and challenges of using breast-dedicated MRI for first-line breast cancer screening in Chinese...
-
Riskonnect Addresses Financial Services and Healthcare Market Risks with New Platform Capabilities
Riskonnect, the leader in integrated risk management (iRM) solutions, today announces the latest version of its platform Riskonnect 2021.1. Among other enhancements, the release delivers two new major capabilities within the governance, risk, and compliance (GRC) suite specifically designed to help UK financial services organizations build resilience and improve decision making. The release also includes several new features within Riskonnect’s Healthcare Patient Safety and Risk Management Solution that...
-
Lilly, Vir Biotechnology and GSK Announce Positive Topline Data from the Phase 2 BLAZE-4 Trial Evaluating Bamlanivimab with VIR-7831 in Low-Risk Adults with COVID-19
Eli Lilly and Company (NYSE: LLY), Vir Biotechnology, Inc. (NASDAQ: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) today announced topline data from the expanded Phase 2 BLAZE-4 trial studying low-risk adult patients with mild to moderate COVID-19. Results showed that investigational bamlanivimab (LY-CoV555) 700 mg co-administered with VIR-7831 (also known as GSK4182136) 500 mg demonstrated a 70 percent (p5.27; cycle threshold value < 27.5) at day 7 compared to placebo, meeting the primary endpoint. In addition,...
-
Lakhmir Chawla, MD, of Silver Creek Pharmaceuticals Joins ExThera Medical Board of Directors
Professor Lakhmir Chawla, MD, has joined the board of directors of ExThera Medical Corporation, a privately held medical technology company whose Seraph 100 Microbind Affinity Blood Filter is authorized in the United States to treat critically ill COVID-19 patients. Dr. Chawla also serves as the Chair of the Scientific Advisory Board at the company Dr. Chawla is an internationally renowned expert in the field of acute kidney injury (AKI), vasopressors, and septic shock. He remains an active investigator in the...
-
Intersect ENT to Participate at the Oppenheimer 31st Annual Healthcare Conference
Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that Tom West, President & Chief Executive Officer, and Randy Meier, Executive Vice President & Chief Financial Officer, will participate in a fireside chat at the Oppenheimer 31st Annual Healthcare Conference. The fireside chat will take place on Wednesday, March 17, 2021 at 2:30 p.m. ET / 11:30 a.m. PT. To access the webcast, go to the...
Customer comments
No comments were found for Looking forward to seeing you at Medical Fair China 2019!. Be the first to comment!